Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
mental disorder
anxiety disorder |
| gptkbp:cause |
Impaired occupational functioning
Impaired social functioning |
| gptkbp:characterizedBy |
Maladaptive behavior change related to attacks
Persistent worry about additional attacks Recurrent unexpected panic attacks |
| gptkbp:class |
gptkb:DSM-5
gptkb:ICD-10 |
| gptkbp:comorbidity |
gptkb:Agoraphobia
Depression Other anxiety disorders |
| gptkbp:hasDiagnosticCriteria |
gptkb:DSM-5
|
| gptkbp:hasSymptomsDuration |
At least one month of persistent concern or behavioral change
|
| https://www.w3.org/2000/01/rdf-schema#label |
Panic Disorder
|
| gptkbp:ICD-10_code |
F41.0
|
| gptkbp:MedlinePlusID |
000924
|
| gptkbp:MeSH_ID |
D016584
|
| gptkbp:OMIM |
167870
|
| gptkbp:onset |
Late adolescence to early adulthood
|
| gptkbp:partOf |
Anxiety disorders spectrum
|
| gptkbp:prevalence |
2-3% of adults annually
|
| gptkbp:riskFactor |
Stress
Genetic predisposition Substance abuse Childhood trauma Family history of anxiety |
| gptkbp:symptom |
gptkb:Nausea
Dizziness Panic attack Shortness of breath Sweating Trembling Chest pain Palpitations Fear of dying Fear of losing control |
| gptkbp:treatment |
gptkb:psychotherapy
gptkb:Cognitive_behavioral_therapy gptkb:Benzodiazepines gptkb:Selective_serotonin_reuptake_inhibitors Psychiatrist Clinical psychologist Lifestyle modification |
| gptkbp:triggeredBy |
Medical conditions
Chronic stress Major life transitions Stimulant use |
| gptkbp:bfsParent |
gptkb:Anti-Anxiety_Agents
|
| gptkbp:bfsLayer |
7
|